Gastrointestinal hemorrhagic vascular disease and small bowel bleeding
Conditions
Interventions
None listed
Sponsors
Fujita Health University School of Medicine, Department of Advanced Endoscopy
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Ppatients who undergo enteroscopy due to suspected small bowel diseases 2) Patients with gastrointestinal vascular disease who undergo endoscopy
Exclusion criteria
Exclusion criteria: Patients who do not provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation and von Willebrand multimer in patients with gaastrointestinal hemorrhagic vascular diseases | — |
Secondary
| Measure | Time frame |
|---|---|
| Atherosclerosis in patients with gaastrointestinal hemorrhagic vascular diseases | — |
Countries
Japan
Contacts
Public ContactNaoki Ohmiya
Fujita Health University Department of Advanced Endoscopy
Outcome results
None listed